Individuals with significant liver disease, kidney disease, active cancer, or complex medical conditions should discuss potential risks and benefits with their healthcare team before considering compounded peptide therapy
Current practice patterns extrapolated from animal studies and online communities typically involve subcutaneous injection of 0.25-0.5 mg once or twice daily, or oral administration of 0.5-1 mg daily to compensate for lower bioavailability
What it can genuinely help with, in dermatology hands, is severe, treatment-resistant pigmentation
Our vitamin B12 injections provide a direct and highly absorbable dose of this important vitamin
So the common question, "how many pills equal one shot," does not have a clean answer
The main difference is the route of administration